Literature DB >> 3384223

Expression of SPARC/osteonectin transcript in murine embryos and gonads.

C C Howe1, G C Overton, J Sawicki, D Solter, P Stein, S Strickland.   

Abstract

A cDNA clone, p2-4, was isolated from mouse teratocarcinoma-derived parietal endoderm-like cells and used to analyze expression of the corresponding transcript during mouse embryogenesis. Nucleotide-sequence analysis revealed extensive homology between this clone and SPARC/osteonectin cDNA cloned from mouse parietal endoderm and bovine bone cells. The SPARC/osteonectin transcript became more abundant when embryonal carcinoma (EC) cells differentiated into parietal endoderm-like cells. In embryos, the transcript began to appear in the embryo proper on day 11 and continued to be expressed throughout the gestation period. The transcript was also present in extraembryonic membranes and placenta from days 9 and 11 onward, respectively. Thus, expression of the transcript was regulated during differentiation of EC cells and during embryogenesis. In adult mice, several non-bone tissues, including testis, also expressed the transcript. Analysis of germ-cell-deficient mice indicated that non-germ-cell components of the testis expressed the transcript. Analysis of mouse testicular cell lines further suggested that the transcript was abundant in Sertoli cells and Leydig cells. Cumulus oophorus cells that envelope the ovulated egg also expressed high levels of the transcript.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3384223     DOI: 10.1111/j.1432-0436.1988.tb00792.x

Source DB:  PubMed          Journal:  Differentiation        ISSN: 0301-4681            Impact factor:   3.880


  9 in total

1.  Osteonectin/SPARC secreted by RPE and localized to the outer plexiform layer of the monkey retina.

Authors:  I R Rodríguez; E F Moreira; D Bok; M Kantorow
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-08       Impact factor: 4.799

2.  CpG methylation of an endogenous retroviral enhancer inhibits transcription factor binding and activity.

Authors:  B T Lamb; K Satyamoorthy; L Li; D Solter; C C Howe
Journal:  Gene Expr       Date:  1991

3.  Identification of an intronic enhancer that nullifies upstream repression of SPARC gene expression.

Authors:  K Satyamoorthy; S J Samulewicz; L D Thornburg; A Basu; C C Howe
Journal:  Nucleic Acids Res       Date:  1997-08-01       Impact factor: 16.971

4.  SPARC synthesis in pre-implantation and early post-implantation mouse embryos.

Authors:  Keith E Latham; Chin C Howe
Journal:  Rouxs Arch Dev Biol       Date:  1991-06

5.  Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens.

Authors:  D T Gilmour; G J Lyon; M B Carlton; J R Sanes; J M Cunningham; J R Anderson; B L Hogan; M J Evans; W H Colledge
Journal:  EMBO J       Date:  1998-04-01       Impact factor: 11.598

6.  Histogenesis of clear cell chondrosarcoma. An immunohistochemical study with osteonectin, a non-collagenous structure protein.

Authors:  A Bosse; Y Ueda; P Wuisman; D B Jones; E Vollmer; A Roessner
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

7.  Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape.

Authors:  T F Lane; E H Sage
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

8.  "In vitro" Effect of Different Follicle-Stimulating Hormone Preparations on Sertoli Cells: Toward a Personalized Treatment for Male Infertility.

Authors:  Iva Arato; Giuseppe Grande; Ferran Barrachina; Catia Bellucci; Cinzia Lilli; Meritxell Jodar; Maria Chiara Aglietti; Francesca Mancini; Federica Vincenzoni; Alfredo Pontecorvi; Riccardo Calafiore; Rafael Oliva; Giovanni Luca; Francesca Mancuso; Domenico Milardi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-18       Impact factor: 5.555

9.  Oocyte-somatic cells interactions, lessons from evolution.

Authors:  Cathy Charlier; Jérôme Montfort; Olivier Chabrol; Daphné Brisard; Thaovi Nguyen; Aurélie Le Cam; Laurent Richard-Parpaillon; François Moreews; Pierre Pontarotti; Svetlana Uzbekova; Franck Chesnel; Julien Bobe
Journal:  BMC Genomics       Date:  2012-10-19       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.